NJ Senator Proposes Bill To Cap Medical Cannabis Prices, Improve Patient Access
In an effort to address high costs and improve accessibility for medical cannabis patients, New Jersey State Senator Troy Singleton introduced Senate Bill 2921 in March of this year.
The bill mandates the Cannabis Regulatory Commission (CRC) to monitor and potentially cap the prices of medical cannabis products. Here’s what this bill could mean for the New Jersey cannabis market.
Price Monitoring and Caps
The proposed legislation requires the CRC to closely track the prices of all medical cannabis products sold by cultivators, manufacturers, dispensaries, and clinical registrants. If the commission finds the prices unreasonable and not reflective of actual costs, it can implement a six-month price cap on these entities. The price cap can be adjusted during this period and re-implemented if necessary, ensuring that the cap does not exceed …